Evidence mounts for need to study Pfizer’s Paxlovid for long COVID – researchers say
By Julie Steenhuysen CHICAGO – Additional reports of patients with long COVID who were helped by Pfizer Inc’s oral antiviral treatment Paxlovid offer fresh impetus for conducting clinical trials to…